477 related articles for article (PubMed ID: 29700887)
21. Primary Spindle Cell Sarcoma of the Lung with
Georgantzoglou N; Aghighi M; Cote G; Hung YP; Kerr DA; Pettus J; Linos K
Int J Surg Pathol; 2022 Dec; 30(8):931-938. PubMed ID: 35388715
[TBL] [Abstract][Full Text] [Related]
22. Sarcoma with MGA-NUTM1 fusion in the lung: an emerging entity.
Goto T; Arai Y; Shibata T; Oyama T; Yoshida A
Virchows Arch; 2020 Feb; 476(2):317-322. PubMed ID: 31385070
[TBL] [Abstract][Full Text] [Related]
23.
Luo W; Stevens TM; Stafford P; Miettinen M; Gatalica Z; Vranic S
Curr Oncol; 2021 Nov; 28(6):4485-4503. PubMed ID: 34898574
[TBL] [Abstract][Full Text] [Related]
24. Primary cutaneous NUT carcinoma with BRD4::NUTM1 fusion.
Shah A; Box A; Brenn T; Flaman A
J Cutan Pathol; 2024 Jun; 51(6):424-429. PubMed ID: 38481096
[TBL] [Abstract][Full Text] [Related]
25. NSD3-NUTM1-rearranged carcinoma of the median neck/thyroid bed developing after recent thyroidectomy for sclerosing mucoepidermoid carcinoma with eosinophilia: report of an extraordinary case.
Agaimy A; Tögel L; Stoehr R; Meidenbauer N; Semrau S; Hartmann A; Mantsopoulos K
Virchows Arch; 2021 Dec; 479(6):1095-1099. PubMed ID: 33891143
[TBL] [Abstract][Full Text] [Related]
26. NUTM1 -rearranged Carcinoma of the Thyroid : A Distinct Subset of NUT Carcinoma Characterized by Frequent NSD3 - NUTM1 Fusions.
Barletta JA; Gilday SD; Afkhami M; Bell D; Bocklage T; Boisselier P; Chau NG; Cipriani NA; Costes-Martineau V; Ghossein RA; Hertzler HJ; Kramer AM; Limaye S; Lopez CA; Ng TL; Weissferdt A; Xu B; Zhang S; French CA
Am J Surg Pathol; 2022 Dec; 46(12):1706-1715. PubMed ID: 36040068
[TBL] [Abstract][Full Text] [Related]
27. Cytomorphology of metastatic colonic MXD4::NUTM1-rearranged sarcoma.
Wilkinson ZA; Policarpio-Nicolas MLC
Diagn Cytopathol; 2024 Jun; 52(6):342-349. PubMed ID: 38595053
[TBL] [Abstract][Full Text] [Related]
28. Emerging entities in NUTM1-rearranged neoplasms.
McEvoy CR; Fox SB; Prall OWJ
Genes Chromosomes Cancer; 2020 Jun; 59(6):375-385. PubMed ID: 32060986
[TBL] [Abstract][Full Text] [Related]
29. YAP1-NUTM1 Gene Fusion in Porocarcinoma of the External Auditory Canal.
Agaimy A; Tögel L; Haller F; Zenk J; Hornung J; Märkl B
Head Neck Pathol; 2020 Dec; 14(4):982-990. PubMed ID: 32436169
[TBL] [Abstract][Full Text] [Related]
30. The expanding universe of NUTM1 fusions in pediatric cancer.
Charlab R; Racz R
Clin Transl Sci; 2023 Aug; 16(8):1331-1339. PubMed ID: 37082775
[TBL] [Abstract][Full Text] [Related]
31. Sarcoma with MGA::NUTM1 fusion: a report of three cases and literature review.
Wangsiricharoen S; Wakely PE; Prieto VG; Yu W
Histopathology; 2023 Nov; 83(5):712-721. PubMed ID: 37442637
[TBL] [Abstract][Full Text] [Related]
32. Clinicopathological molecular characterizations of sinonasal NUT carcinoma: a report of two cases and a literature review.
Chen M; Li S; Jiang L
Front Oncol; 2023; 13():1296862. PubMed ID: 38239638
[TBL] [Abstract][Full Text] [Related]
33. Superficial sarcomas with CIC rearrangement are aggressive neoplasms: A series of eight cases.
Ko JS; Marusic Z; Azzato EM; Farkas DH; Van Arnam J; Seiwerth S; Fritchie K; Patel RM; Rubin BP; Billings SD
J Cutan Pathol; 2020 Jun; 47(6):509-516. PubMed ID: 32026485
[TBL] [Abstract][Full Text] [Related]
34. Expanding the Molecular Diversity of CIC-Rearranged Sarcomas With Novel and Very Rare Partners.
Linos K; Dermawan JK; Bale T; Rosenblum MK; Singer S; Tap W; Dickson MA; Hornick JL; Antonescu CR
Mod Pathol; 2023 May; 36(5):100103. PubMed ID: 36788092
[TBL] [Abstract][Full Text] [Related]
35. "Z4" Complex Member Fusions in NUT Carcinoma: Implications for a Novel Oncogenic Mechanism.
Shiota H; Elya JE; Alekseyenko AA; Chou PM; Gorman SA; Barbash O; Becht K; Danga K; Kuroda MI; Nardi V; French CA
Mol Cancer Res; 2018 Dec; 16(12):1826-1833. PubMed ID: 30139738
[TBL] [Abstract][Full Text] [Related]
36. Clinical and molecular features of pulmonary NUT carcinoma characterizes diverse responses to immunotherapy, with a pathologic complete response case.
Chen M; Chen X; Zhang Y; Wang W; Jiang L
J Cancer Res Clin Oncol; 2023 Aug; 149(9):6361-6370. PubMed ID: 36752907
[TBL] [Abstract][Full Text] [Related]
37. Central nervous system sarcoma with ATXN1::DUX4 fusion expands the concept of CIC-rearranged sarcoma.
Satomi K; Ohno M; Kubo T; Honda-Kitahara M; Matsushita Y; Ichimura K; Narita Y; Ichikawa H; Yoshida A
Genes Chromosomes Cancer; 2022 Nov; 61(11):683-688. PubMed ID: 35715887
[TBL] [Abstract][Full Text] [Related]
38. Novel ATXN1/ATXN1L::NUTM2A fusions identified in aggressive infant sarcomas with gene expression and methylation patterns similar to CIC-rearranged sarcoma.
Xu F; Viaene AN; Ruiz J; Schubert J; Wu J; Chen J; Cao K; Fu W; Bagatell R; Fan Z; Long A; Pagliaroli L; Zhong Y; Luo M; Kreiger PA; Surrey LF; Wertheim GB; Cole KA; Li MM; Santi M; Storm PB
Acta Neuropathol Commun; 2022 Jul; 10(1):102. PubMed ID: 35836290
[TBL] [Abstract][Full Text] [Related]
39. NUT Is a Specific Immunohistochemical Marker for the Diagnosis of YAP1-NUTM1-rearranged Cutaneous Poroid Neoplasms.
Macagno N; Kervarrec T; Sohier P; Poirot B; Haffner A; Carlotti A; Balme B; Castillo C; Jullie ML; Osio A; Lehmann-Che J; Frouin E; Battistella M
Am J Surg Pathol; 2021 Sep; 45(9):1221-1227. PubMed ID: 33739783
[TBL] [Abstract][Full Text] [Related]
40. NUT Carcinoma: Clinicopathologic Features, Molecular Genetics and Epigenetics.
Moreno V; Saluja K; Pina-Oviedo S
Front Oncol; 2022; 12():860830. PubMed ID: 35372003
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
